Markets›Health care›PFE

Pfizer

PFE
28.67
+0.26 (+0.92%)
Closing price for Sep 25, 2026 from Polygon.io

Valuation

Market value163.41B
Enterprise value225.63B
Price to earnings (P/E)37.7
Price to sales2.6
Price to book1.9
Free cash flow yield6.7%

Profitability (last 12 months)

Revenue63.70B
Net income4.33B
Gross margin73.2%
Net margin6.8%
Return on equity5.1%
Return on assets2.2%

Growth (last fiscal year, FY 2025)

Revenue growth-1.6%
EPS growth-3.5%

Balance sheet (latest quarter)

Cash and equivalents976.00M
Total debt63.19B
Debt to equity0.74
Current ratio1.27

Per share and dividends

EPS, diluted (last 12 months)0.76
Shares outstanding5.70B
Dividends paid (last 12 months)None

Trading

Price28.67
52-week high29.21
52-week low23.62
1-year price change+20.21%
Average volume (3 months)38.18M
Beta against the S&P 500 (1 year)0.33

Calculated from Pfizer's SEC filings (latest quarter ending Jun 28, 2026) and the price above. "Last 12 months" adds up the four most recent quarters. Beta compares one year of daily returns with the S&P 500 (SPY). Dividends from Polygon.io or Nasdaq.